Therefore, its long-term safety is uncertain and may vary depending on the compounding process by the compounding pharmacy you purchase from
People with a BMI of 27 or higher may also qualify if they have a health issue linked to their weight, such as high blood pressure, high cholesterol, or type 2 diabetes
These are not FDA-approved medications and may vary in formulation, strength, and quality
Both can be prescribed by licensed clinicians in appropriate clinical circumstances, but the regulatory and quality distinctions are real and material
Association between midlife obesity and kidney function trajectories: The Atherosclerosis Risk in Communities (ARIC) study
Key Takeaways Retatrutide is a triple hormone receptor agonist that targets both fat loss and muscle preservation, enabling weight management for obesity